Cresset Asset Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,832
Closed -$25K 1054
2022
Q1
$25K Buy
+11,832
New +$28.8K ﹤0.01% 979
2021
Q4
Sell
-10,588
Closed -$53K 1257
2021
Q3
$53K Buy
+10,588
New +$61K ﹤0.01% 1095

Other funds holding PGEN

Cresset Asset Management's PGEN Position: Q2 2022 in Review

Cresset Asset Management sold out of Precigen (PGEN) in Q2 2022, closing a stake of 11,832 shares — an estimated $25K sold.

Cresset Asset Management first reported a position in PGEN in Q3 2021 and held it in 2 quarters. The position peaked at $53K in Q3 2021. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2022.

  • Cresset Asset Management reported no remaining Precigen position as of Q2 2022 after selling out during the quarter.
  • Cresset Asset Management sold 11,832 Precigen shares in Q2 2022, an estimated $25K.
  • Cresset Asset Management first reported a position in Precigen in Q3 2021 and held it in 2 quarters.
  • Cresset Asset Management's Precigen position peaked at $53K in Q3 2021.
  • 169 funds tracked by Wall St. Rank held Precigen as of Q2 2022.

Based on Cresset Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.